Contact this trialFirst, we need to learn more about you.
Immunotherapy
Nivolumab + BMS-813160 +/- GVAX for Pancreatic Cancer
Recruiting1 awardPhase 1 & 2
Baltimore, Maryland
This trial will test a combination of three drugs to treat patients with locally advanced pancreatic cancer. The goal is to see if the combination is safe and if it enhances the infiltration of CD8+CD137+ cells in pancreatic ductal adenocarcinomas (PDACs).
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.